The DOI matches its Crossref record.
A C-Terminal Fragment of Agouti-Related Protein Increases Feeding and Antagonizes the Effect of Alpha-Melanocyte Stimulating Hormone in Vivo
Abstract
Agouti-related protein (Agrp) is present in rat and human hypothalamus and is structurally related to agouti protein. Overexpression of either of these proteins results in obesity. However the effect of exogenous Agrp and its in vivo interaction with alpha-melanocyte stimulating hormone (alphaMSH), the likely endogenous melanocortin 3 and 4 receptor (MC3-R and MC4-R) agonist, have not been demonstrated. We report that 1 nmol of Agrp(83-132), a C-terminal fragment of Agrp, when administered intracerebroventricularly (ICV) into rats, increased food intake over a 24-h period (23.0+/-1.4 g saline vs 32.9+/-2.3 g Agrp, p<0.05). The hyperphagia was similar to that seen when 1 nmol of the synthetic MC3-R and MC4-R antagonist SHU9119 was given i.c.v. (19.6+/-1.8 g saline vs 32.5+/-1.7 g SHU9119, p<0.001). Both Agrp(83-132) and SHU9119 blocked the reduction in 1-h food intake of i.c.v. alphaMSH at the beginning of the dark phase. This effect occurred independently of whether the antagonists were administered simultaneously, or nine hours prior, to the alphaMSH. We have also shown Agrp(83-132) is an antagonist at the MC3-R and MC4-R, with similar inhibition of cAMP activation to that previously reported for the full length peptide. In conclusion, Agrp(83-132) administered i.c.v. increases feeding with long lasting effects and is able to inhibit the action of alphaMSH. This interaction may be mediated by the MC3-R and/or MC4-R.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast to its pro-opiomelanocortin-stimulating action, insulin inhibits NPY expression144 in Agouti-related peptide (AgRP/NPY) neurons, which are known to secrete the orexigenic neuropeptides NPY145, 146, 147 and AgRP.148, 149”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [149]
Citations
Cited by
Sorted by citations
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training
Aponte, Y., Atasoy, D., & Sternson, S. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2739 · Cited by 1,157
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
Genetics of body-weight regulation
Barsh, G. S., Farooqi, I. S., & O’Rahilly, S. (2000) · Nature · doi:10.1038/35007519 · Cited by 783
“Pharmacological and transgenic experiments have revealed that obesity in A y mutant mice reflects the ability of agouti protein abnormally expressed in the brain to mimic the neuropeptide agouti-related protein (Agrp), which is normally expressed in the hypothalamus and signals through the central nervous system (CNS)…”
BackgroundIntegration of NPY, AGRP, and Melanocortin Signals in the Hypothalamic Paraventricular Nucleus
Cowley, M. A., Pronchuk, N., Fan, W., Dinulescu, D. M., Colmers, W. F., & Cone, R. D. (1999) · Neuron · doi:10.1016/s0896-6273(00)80829-6 · Cited by 612
“In rats, for example, following caloric restric- lates feeding (Rossi et al., 1998).”
Toward a Wiring Diagram Understanding of Appetite Control
Andermann, M. L., & Lowell, B. B. (2017) · Neuron · doi:10.1016/j.neuron.2017.06.014 · Cited by 633
Kamegai, J., Tamura, H., Shimizu, T., Ishii, S., Sugihara, H., & Wakabayashi, I. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2438 · Cited by 624
“The simultaneous release of AGRP antagonizes the melanocortin-4 receptor, which suppresses the anorectic effects of -MSH (12).”
BackgroundThe Melanocortin-4 Receptor: Physiology, Pharmacology, and Pathophysiology
Tao, Y.-X. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0037 · Cited by 531
“(167) showed that ICV administration of NDP-MSH decreases food intake, but treatments with SHU9119 or AgRP fail to stimulate food intake, different from the results obtained in rodents (50, 87, 138) and sheep (168).”
BackgroundResultMetabolism and Circadian Rhythms—Implications for Obesity
Froy, O. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0014 · Cited by 505
Role of neuropeptides in appetite regulation and obesity – A review
Arora, S., & Anubhuti, A. (2006) · Neuropeptides · doi:10.1016/j.npep.2006.07.001 · Cited by 471
Wynne, K., Stanley, S., McGowan, B. M., & Bloom, S. R. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.05866 · Cited by 478
Self-citationA neural basis for melanocortin-4 receptor–regulated appetite
Garfield, A. S., Li, C., Madara, J. C., Shah, B. P., Webber, E. S., Steger, J. S., Campbell, J. N., Gavrilova, O., Lee, C. E., Olson, D. P., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4011 · Cited by 447
Bagnol, D., Lu, X.-Y., Kaelin, C. B., Day, H. E. W., Ollmann, M., Gantz, I., Akil, H., Barsh, G. S., & Watson, S. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-j0004.1999 · Cited by 425
“Artificial increases in AGRP achieved pharmacologically or in transgenic animals cause elevated food intake and obesity (Graham et al., 1997; Ollmann et al., 1997; Grill et al., 1998; Rossi et al., 1998).”
BackgroundAgRP(83-132) Acts as an Inverse Agonist on the Human-Melanocortin-4 Receptor
Nijenhuis, W. A. J., Oosterom, J., & Adan, R. A. H. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.1.0578 · Cited by 408
“Considerable evidence exists suggesting that AgRP is involved in body weight regulation (11, 12, 23, 24 ) by acting downstream of the adipose tissue-derived satiety factor leptin (25, 26).”
BackgroundKrashes, M. J., Shah, B. P., Koda, S., & Lowell, B. B. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.009 · Cited by 373
“The pharmacological administration of either NPY or AgRP into the hypothalamus induces a robust hyperphagic response in rodents (Clark et al., 1984; Rossi et al., 1998; Semjonous et al., 2009) with distinct temporal dynamics; NPY results in immediate feeding, whereas AgRP increases food intake over a delayed, longer t…”
Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity
Silva, A. D., & Bloom, S. R. (2012) · Gut and Liver · doi:10.5009/gnl.2012.6.1.10 · Cited by 373
“Furthermore, AgRP is a competitive antagonist at melanocortin receptors.(15) CART is thought to have either orexigenic or anorexigenic effects depending on its site of action; central intracerebroventricular administration of CART reduces food intake in rats,(16) whereas administration of CART directly into the ARC in…”
BackgroundSelf-citationMice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean
Yamada, M., Miyakawa, T., Duttaroy, A., Yamanaka, A., Moriguchi, T., Makita, R., Ogawa, M., Chou, C. J., Xia, B., Crawley, J. N., et al. (2001) · Nature · doi:10.1038/35065604 · Cited by 373
“To examine the mechanism by which the lack of M3 receptors interferes with neuropeptide-dependent feeding behaviour, M3R -/- and wild-type mice received intracerebroventricular infusions of AGRP 83-132 (an AGRP analogue”
MethodHormonal regulation of food intake
Stanley, S., Wynne, K., McGowan, B., & Bloom, S. (2005) · Physiological Reviews · doi:10.1152/physrev.00015.2004 · Cited by 372
“Central administration of AgRP or AgRP(83O132), the carboxy-terminal fragment, is able to block -MSH-induced anorexia and increase nocturnal food intake (337).”
BackgroundSelf-citationLeptin and the Central Nervous System Control of Glucose Metabolism
Morton, G. J., & Schwartz, M. W. (2011) · Physiological Reviews · doi:10.1152/physrev.00007.2010 · Cited by 338
“One of these subsets expresses neuropeptide Y (NPY) and agouti related peptide (AgRP), peptides that stimulate food intake and inhibit energy expenditure, thereby promoting positive energy balance (75, 153, 178).”
BackgroundSatiation, satiety and their effects on eating behaviour
Benelam, B. (2009) · Nutrition Bulletin · doi:10.1111/j.1467-3010.2009.01753.x · Cited by 366
Food Intake and the Regulation of Body Weight
Woods, S. C., Schwartz, M. W., Baskin, D. G., & Seeley, R. J. (2000) · Annual Review of Psychology · doi:10.1146/annurev.psych.51.1.255 · Cited by 335
“Increased leptin in turn attenuates the activation of the ARC NPY neurons, simulating the effect that would normally occur in response to elevated body fuel stores (Schwartz et al 1996a,b).”
BackgroundInfluentialHagan, M. M., Rushing, P. A., Pritchard, L. M., Schwartz, M. W., Strack, A. M., der Ploeg, L. H. T. V., Woods, S. C., & Seeley, R. J. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.1.r47 · Cited by 320
“This rather unique mechanism was suggested by previous findings that AgRP-(83O132) blocked anorexia induced by the MC3/4-R agonist a-MSH delivered up to 9 h subsequently (32).”
BackgroundResultThe role of gut hormones and the hypothalamus in appetite regulation
Suzuki, K., Simpson, K. A., MINNION, J. S., Shillito, J. C., & Bloom, S. R. (2010) · Endocrine Journal · doi:10.1507/endocrj.k10e-077 · Cited by 327
Self-citationLiu, Y., Connoley, I. P., WILSON, C. A., & Stock, M. J. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802847 · Cited by 314
Fekete, C., Légrádi, G., Mihály, E., Huang, Q.-H., Tatro, J. B., Rand, W. M., Emerson, C. H., & Lechan, R. M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-04-01550.2000 · Cited by 308
The defence of body weight: a physiological basis for weight regain after weight loss
Sumithran, P., & Proietto, J. (2013) · Clinical Science · doi:10.1042/cs20120223 · Cited by 310
Haynes, A. C., Jackson, B., Overend, P., Buckingham, R. E., Wilson, S., Tadayyon, M., & Arch, J. R. S. (1999) · Peptides · doi:10.1016/s0196-9781(99)00105-9 · Cited by 303
Hunger-Driven Motivational State Competition
Burnett, C. J., Li, C., Webber, E., Tsaousidou, E., Xue, S. Y., Brüning, J. C., & Krashes, M. J. (2016) · Neuron · doi:10.1016/j.neuron.2016.08.032 · Cited by 305
“ARCAgRP neurons express the neuromodulators Agoutirelated peptide and Neuropeptide Y, along with the fast transmitter GABA, all of which influence feeding behavior (Clark et al., 1984; Krashes et al., 2013; Rossi et al., 1998; Stanley and Leibowitz, 1985; Stratford and Kelley, 1997).”
BackgroundNeuropeptides, food intake and body weight regulation: a hypothalamic focus
Hillebrand, J. J., de Wied, D., & Adan, R. A. H. (2002) · Peptides · doi:10.1016/s0196-9781(02)00269-3 · Cited by 291
Hypothalamic Agrp Neurons Drive Stereotypic Behaviors beyond Feeding
Dietrich, M. O., Zimmer, M. R., Bober, J., & Horváth, T. L. (2015) · Cell · doi:10.1016/j.cell.2015.02.024 · Cited by 271
“the brain elicit robust increases in food intake (Clark et al., 1984; Ollmann et al., 1997; Rossi et al., 1998; Stanley et al., 1986), and food deprivation increases the activity of these neurons (Hahn et al.”
All Bariatric Surgeries Are Not Created Equal: Insights from Mechanistic Comparisons
Stefater, M. A., Wilson, H., Chambers, A. P., Sandoval, D. A., & Seeley, R. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1044 · Cited by 289
Insulin and Leptin as Adiposity Signals
Benoit, S. C. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.267 · Cited by 266
“Experiments in which animals were rendered obese, then placed on a low(er)-fat diet, have been somewhat equivocal, with some reporting loss of body weight (Hill et al., 1992) and others no weight reduction (Faust et al., 1978; Rolls et al., 1980; Harris et al., 1986; Uhley and Jen, 1989; Hill et al., 1992).”
BackgroundNeurochemical Characterization of Hypothalamic Cocaine—Amphetamine-Regulated Transcript Neurons
Vrang, N., Larsen, P. J., Clausen, J. T., & Kristensen, P. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-10-j0006.1999 · Cited by 264
“Also, C-terminal fragments of AgRP potently stimulate food intake when injected intracerebroventricularly (Rossi et al., 1998).”
BackgroundThe MC4 receptor and control of appetite
Adan, R. A. H., Tiesjema, B., Hillebrand, J. J., la Fleur, S. E., Kas, M. J., & de Krom, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706929 · Cited by 267
“A single central administration of AgRP increases food intake for at least 24 h (up to 7 days) and blocks a-MSH/MTII-induced hypophagia (Rossi et al., 1998; Hagan et al., 2000; Wirth and Giraudo, 2000).”
BackgroundCrespo, C. S., Cachero, A. P., Puebla, L., Barrios, V., & Arilla, E. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00058 · Cited by 274
“ICV infusion or systemic injection of insulin results in a dose-dependent suppression of food intake.”
BackgroundKim, M. S., Small, C. J., Stanley, S. A., Morgan, D. G. A., Seal, L. J., Kong, W. M., Edwards, C. M. B., Abusnana, S., Sunter, D., Ghatei, M. A., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8857 · Cited by 256
“This dose of Agrp (83-132) was previously found to produce a significant increase in food intake (23).”
BackgroundSelf-citationLeptin action in the forebrain regulates the hindbrain response to satiety signals
Morton, G. J., Blevins, J. E., Williams, D. L., Niswender, K. D., Gelling, R. W., Rhodes, C. J., Baskin, D. G., & Schwartz, M. W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22081 · Cited by 253
Gut hormones in the control of appetite
Murphy, K. G., & Bloom, S. R. (2004) · Experimental Physiology · doi:10.1113/expphysiol.2004.027789 · Cited by 261
“AgRP is the endogenous antagonist of the MC3 and MC4 receptors, and central injection of AgRP dramatically increases food intake (Rossi et al. 1998).”
BackgroundSelf-citationBrown fat biology and thermogenesis
Richard, D. (2010) · Frontiers in bioscience · doi:10.2741/3786 · Cited by 251
“It is overexpressed in obese mice (175) and, when injected centrally, reduces BAT thermogenesis (187) while increasing food intake (187, 188).”
BackgroundLu, X., Barsh, G. S., Akil, H., & Watson, S. J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07863.2003 · Cited by 240
Bäckberg, M., Hervieu, G. J., Wilson, S., & Meister, B. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01859.x · Cited by 235
“As administration of MCH i.c.v. produces an acute stimulatory effect on food intake (Rossi et al., 1998), and because orexins are appetite stimulators, it appears reasonable to anticipate that orexins have an excitatory effect on closely located MCH neurons.”
BackgroundInfluentialHypothalamic control of energy balance: different peptides, different functions
LEIBOWITZ, S. F., & Wortley, K. E. (2004) · Peptides · doi:10.1016/j.peptides.2004.02.006 · Cited by 241
“As with NPY, central injection of AgRP has a potent stimulatory effect on food intake [141], similar to the response induced by a synthetic melanocortin receptor antagonist [342].”
Neural Control of Energy Balance: Translating Circuits to Therapies
Gautron, L., Elmquist, J. K., & Williams, K. W. (2015) · Cell · doi:10.1016/j.cell.2015.02.023 · Cited by 250
Postembryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype
Bewick, G. A., Gardiner, J., Dhillo, W. S., Kent, A. S., White, N. E., Webster, Z., Ghatei, M. A., & Bloom, S. R. (2005) · The FASEB Journal · doi:10.1096/fj.04-3434fje · Cited by 253
“AgRP and NPY are both powerful orexigenic agents (32, 33).”
BackgroundSelf-citationFuture Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon
Srivastava, G., & Apovian, C. (2018) · Current Obesity Reports · doi:10.1007/s13679-018-0300-4 · Cited by 232
Hypothalamic neuropeptides and the regulation of appetite
Parker, J., & Bloom, S. R. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.02.004 · Cited by 242
Self-citationMonitoring of stored and available fuel by the CNS: implications for obesity
Seeley, R. J., & Woods, S. C. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1245 · Cited by 233
Lateral hypothalamic neuropeptides in reward and drug addiction
Dileone, R., Georgescu, D., & Nestler, E. J. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00408-9 · Cited by 220
Adiposity signals and the control of energy homeostasis
Woods, S. C., & Seeley, R. J. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00454-8 · Cited by 221
Yosten, G. L. C., & Samson, W. K. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90867.2008 · Cited by 209
Physiological and Anatomical Circuitry between Agouti-Related Protein and Leptin Signaling
Wilson, B. D., Bagnol, D., Kaelin, C. B., Ollmann, M. M., Gantz, I., Watson, S. J., & Barsh, G. S. (1999) · Endocrinology · doi:10.1210/endo.140.5.6728 · Cited by 203
“injection of an AGRP fragment increases feeding (8), but little”
BackgroundNillni, E. A. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.01.001 · Cited by 206
FoxO1 Target Gpr17 Activates AgRP Neurons to Regulate Food Intake
Ren, H., Orozco, I. J., Su, Y., Suyama, S., Juárez, R. G., Horváth, T. L., Wardlaw, S. L., Plum, L., Arancio, O., & Accili, D. (2012) · Cell · doi:10.1016/j.cell.2012.04.032 · Cited by 201
“For example, transgenic overexpression of Agrp results in obesity, and acute intracerebroventricular (ICV) delivery of AgRP or neuropeptide Y (NPY), another peptide produced in AgRP neurons, elicits hyperphagia (Levine et al., 2004; Ollmann et al., 1997; Rossi et al., 1998).”
The endocrinology of food intake
Begg, D. P., & Woods, S. C. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.136 · Cited by 214
Jitrapakdee, S. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.001 · Cited by 202
Ingvartsen, K. L., & Boisclair, Y. R. (2001) · Domestic Animal Endocrinology · doi:10.1016/s0739-7240(02)00119-4 · Cited by 203
The melanocortin system and energy balance
Butler, A. A. (2006) · Peptides · doi:10.1016/j.peptides.2005.02.029 · Cited by 203
“The central administration of AgRP, an antagonist of the MC3R and MC4R, increases appetite, weight gain and adiposity when administered centrally or overexpressed in transgenic mice [25,51,52,55].”
InfluentialAppetite regulation: from the gut to the hypothalamus
Neary, N. M., Goldstone, A. P., & Bloom, S. R. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01839.x · Cited by 203
“In contrast to the potent but relatively short-lived effects of NPY, central administration of AgRP to rodents leads to an increase in food intake for up to 1 week (Rossi et al. , 1998).”
BackgroundSelf-citationVogt, M. C., & Brüning, J. C. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.11.004 · Cited by 194
Neuropeptides and appetite control
Wilding, J. P. H. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00790.x · Cited by 195
Obesity: Current and potential pharmacotherapeutics and targets
Narayanaswami, V., & Dwoskin, L. P. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.10.015 · Cited by 188
“Acutely, α-MSH (1 nmol/10 μl, ICV) decreases food intake in rats (Rossi et al., 1998).”
Functional Characterization of Melanocortin-4 Receptor Mutations Associated with Childhood Obesity
Tao, Y., & Segaloff, D. L. (2003) · Endocrinology · doi:10.1210/en.2003-0524 · Cited by 186
“Thus, injection of melanotan II, an agonist of MC3R and MC4R, into the third ventricle decreased food intake (29, 30), whereas injection of the Cterminal peptide of AgRP, an antagonist of these receptors, increased food intake ( 31 ).”
BackgroundWilliams, D. L., Kaplan, J. M., & Grill, H. J. (2000) · Endocrinology · doi:10.1210/endo.141.4.7410 · Cited by 182
Benoit, S. C., Schwartz, M. W., Lachey, J. L., Hagan, M. M., Rushing, P. A., Blake, K. A., Yagaloff, K. A., Kurylko, G., Franco, L., Danhoo, W., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03442.2000 · Cited by 178
“Consequently, genetic overexpression of AgRP or exogenous administration of an AgRP fragment increases food intake and causes obesity but does not alter pigmentation (Ollmann et al., 1997; Rossi et al., 1998).”
BackgroundSelf-citationYosten, G. L. C., & Samson, W. K. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00804.2009 · Cited by 178
“To test this hypothesis, we pretreated rats with either saline or OVT intracerebroventricularly prior to central administration of saline or an anorexigenic dose of -MSH (24).”
MethodGlycolysis in the control of blood glucose homeostasis
Guo, X., Li, H., Xu, H., Woo, S., Dong, H., Lu, F., Lange, A. J., & Wu, C. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.06.002 · Cited by 184
Association between an agouti-related protein gene polymorphism and anorexia nervosa
Vink, T., Hinney, A., Elburg, A. A. V., van Goozen, S. H. M., Sandkuijl, L. A., Sinke, R. J., Herpertz-Dahlmann, B.-M., Hebebrand, J., Remschmidt, H., van Engeland, H., et al. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000854 · Cited by 174
Cerdá‐Reverter, J. M., Ringholm, A., Schiöth, H. B., & Peter, R. E. (2003) · Endocrinology · doi:10.1210/en.2002-0213 · Cited by 171
“In contrast, AGRP is mainly produced within the hypothalamic arcuate nucleus and the adrenal gland, and it is potent in inhibiting melanocortin signaling at MC3R and MC4R but is not active at MC1R (11).”
BackgroundInfluentialFekete, C., Mihály, E., Luo, L.-G., Kelly, J., Clausen, J. T., Mao, Q., Rand, W. M., Moss, L. G., Kuhar, M., Emerson, C. H., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09224.2000 · Cited by 163
“melanocortin receptors (Rossi et al., 1998), is capable of restoring TRH mRNA content in the PVN to normal levels when infused intracerebroventricularly to fasted animals, suggesting that a-MSH may stimulate the biosynthesis of TRH (Fekete et al.”
BackgroundThe role of leptin in health and disease
Ramos-Lobo, A. M., & Donato, J. (2017) · Temperature · doi:10.1080/23328940.2017.1327003 · Cited by 172
“Consequently, AgRP blocks the capacity of a-MSH to activate MC3R/MC4R, which also leads to an increase in food intake.(70,77) Finally, several pieces of evidence also indicate that the inhibitory GABAergic transmission of these neurons is important to modulate neural circuits involved in feeding behavior.”
BackgroundEating Elicited by Orexin-A, But Not Melanin-Concentrating Hormone, Is Opioid Mediated
Clegg, D. J., Air, E. L., Woods, S. C., & Seeley, R. J. (2002) · Endocrinology · doi:10.1210/endo.143.8.8977 · Cited by 160
“This dose of AgRP elicits a reliable and long-lasting increase in food intake (25, 26, 38).”
Morton, G. J., Niswender, K. D., Rhodes, C. J., Myers, M. G., Blevins, J. E., Baskin, D. G., & Schwartz, M. W. (2003) · Endocrinology · doi:10.1210/en.2002-0115 · Cited by 158
The central melanocortin system regulates food intake in goldfish
Cerdá‐Reverter, J. M., Schiöth, H. B., & Peter, R. E. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00144-7 · Cited by 159
Fuel utilization by hypothalamic neurons: roles for ROS
Horváth, T. L., Andrews, Z. B., & Diano, S. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.10.003 · Cited by 165
Alcantara, I. C., Tapia, A. P. M., Aponte, Y., & Krashes, M. J. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00611-y · Cited by 155
Role of the Central Melanocortin Circuitry in Adaptive Thermogenesis of Brown Adipose Tissue
Voss-Andreae, A., Murphy, J. G., Ellacott, K. L. J., Stuart, R. C., Nillni, E. A., Cone, R. D., & Fan, W. (2006) · Endocrinology · doi:10.1210/en.2006-1389 · Cited by 155
“The dose of AgRP was chosen based on efficacy in previous studies in which icv injection of 1 nmol AgRP (83–132) significantly stimulated food intake ( 34 ).”
MethodMcMinn, J. E., Wilkinson, C. W., Havel, P. J., Woods, S. C., & Schwartz, M. W. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.2.r695 · Cited by 156
Neuronal control of energy homeostasis
Gao, Q., & Horváth, T. L. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.063 · Cited by 160
Small, C. J., Kim, M. S., Stanley, S. A., Mitchell, J. R. D., Murphy, K. G., Morgan, D. G. A., Ghatei, M. A., & Bloom, S. R. (2001) · Diabetes · doi:10.2337/diabetes.50.2.248 · Cited by 156
“AGRP (83-132), an MC3/4-R antagonist (16,38), was purchased from Phoenix”
BackgroundMethodInfluentialSelf-citationNutrition and human health from a sex–gender perspective
Marino, M., Masella, R., Bulzomi, P., Campesi, I., Malorni, W., & Franconi, F. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.02.001 · Cited by 159
Hypothalamic proopiomelanocortin processing and the regulation of energy balance
Wardlaw, S. L. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.107 · Cited by 153
“Creemers et al. have shown PC1/3 is expressed in AgRP neurons and is responsible for the generation of AgRP83–132 (Creemers et al., 2006).”
InfluentialSergeyev, V., Broberger, C., & Hökfelt, T. G. M. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00088-2 · Cited by 156
Regulation of Metabolism and Body Fat Mass by Leptin
Baile, C. A., Della‐Fera, M. A., & Martin, R. J. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.105 · Cited by 152
Nesfatin-1 increases anxiety- and fear-related behaviors in the rat
Merali, Z., Cayer, C., Kent, P., & Anisman, H. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1252-2 · Cited by 152
“For example, central administration of melanocortin agonists such as α-MSH or MTII reduce food intake ( Rossi et al. 1998; Vergoni and Bertolini 2000).”
BackgroundMakimura, H., Mizuno, T. M., Mastaitis, J. W., Agami, R., & Mobbs, C. V. (2002) · BMC Neuroscience · doi:10.1186/1471-2202-3-18 · Cited by 150
“Nevertheless the lack of an effect on food intake was unexpected since treatment with synthetic AGRP peptides has profound effects on food intake [4,5].”
BackgroundTwo important systems in energy homeostasis: melanocortins and melanin-concentrating hormone
Tritos, N. A., & Maratos–Flier, E. (1999) · Neuropeptides · doi:10.1054/npep.1999.0055 · Cited by 148
Franke, K., Harder, T., Aerts, L., Melchior, K., Fahrenkrog, S., Rodekamp, E., Ziska, T., Assche, F. A. V., Dudenhausen, J. W., & Plagemann, A. (2004) · Brain Research · doi:10.1016/j.brainres.2004.11.006 · Cited by 147
Neuropeptide Y, α-melanocyte–stimulating hormone, and monoamines in food intake regulation
Ramos, E. J. B., Meguid, M. M., Campos, A. C. L., & Coelho, J. C. U. (2005) · Nutrition · doi:10.1016/j.nut.2004.06.021 · Cited by 148
“, HS014, HS024, -MSH-[3-11], and HS028) timulates food intake [48,51,52], and MC4-R–deficient ice [53] and humans [54] have an obese phenotype.”
BackgroundTHE CRITICAL ROLE OF THE MELANOCORTIN SYSTEM IN THE CONTROL OF ENERGY BALANCE
Seeley, R. J., Drazen, D. L., & Clegg, D. J. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132428 · Cited by 145
Opioid receptor involvement in the effect of AgRP- (83–132) on food intake and food selection
Hagan, M. M., Rushing, P. A., Benoit, S. C., Woods, S. C., & Seeley, R. J. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.3.r814 · Cited by 143
Liu, J., Garza, J. C., Truong, H. V., Henschel, J., Zhang, W., & Lu, X.-Y. (2007) · Endocrinology · doi:10.1210/en.2007-0745 · Cited by 141
Chen, P., Li, C., Haskell‐Luevano, C., Cone, R. D., & Smith, M. S. (1999) · Endocrinology · doi:10.1210/endo.140.6.6829 · Cited by 139
“It has been shown that AGRP exerts its function by binding to two of the receptors (MC3-R and MC4-R) for the POMC peptides (POMC) and preventing their activation by POMC peptides (10, 11, 22).”
Fekete, C., & Lechan, R. M. (2007) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.04.002 · Cited by 137
“The arcuate nucleus contains at least two, distinct populations of neurons that are directly regulated by leptin [67;68;69;70;71], involved in the regulation of feeding behavior [71;72], and project to TRH neurons in the PVN [8;43;44;50].”
BackgroundSong, Y., Golling, G., Thacker, T. L., & Cone, R. D. (2003) · Endocrine · doi:10.1385/endo:22:3:257 · Cited by 137
Agouti and Agouti-related Protein: Analogies and Contrasts
Dinulescu, D. M., & Cone, R. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.6695 · Cited by 132
Agouti: from Mouse to Man, from Skin to Fat
Voisey, J., & van Daal, A. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.00039.x · Cited by 132
He, Z., Gao, Y., Lieu, L., Afrin, S., Cao, J., Michael, N. J., Dong, Y., Sun, J., Guo, H., & Williams, K. W. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.07.008 · Cited by 128
GABAergic signaling by AgRP neurons prevents anorexia via a melanocortin-independent mechanism
Wu, Q., & Palmiter, R. D. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.110 · Cited by 143
“Likewise, intracranial injection of AgRP has a long-lasting stimulatory effect on feeding and genetic over-expression of Agrp in the brain leads to obesity (Broberger and Hokfelt, 2001; Ollmann and Barsh, 1999; Rossi et al., 1998; Shutter et al., 1997).”
BackgroundFekete, C., Sarkar, S., Rand, W. M., Harney, J. W., Emerson, C. H., Bianco, A. C., & Lechan, R. M. (2002) · Endocrinology · doi:10.1210/en.2002-220338 · Cited by 131
“AGRP acts as a competitive antagonist to-MSH at melanocortin receptors ( 12 ) and has both orexigenic and weight promoting properties (12).”
BackgroundInfluentialSignals that influence food intake and body weight
WOODS, S. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.08.060 · Cited by 131
Metadata
- Authors
- Rossi, M., Kim, M. S., Morgan, D. G. A., Small, C. J., Edwards, C. M. B., Sunter, D., Abusnana, S., Goldstone, A. P., Russell, S. H., Stanley, S. A., Smith, D. M., Yagaloff, K., Ghatei, M. A., & Bloom, S. R.
- Affiliations
- Hammersmith Hospital (GB)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1998-10
- Volume
- 139
- Issue
- 10
- Pages
- 4428-4431
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2171010063
- Cited by
- 576
- References
- 0
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 4 · 2023: 5 · 2022: 9 · 2021: 11 · 2020: 7 · 2019: 16 · 2018: 8 · 2017: 13 · 2016: 16 · 2015: 15 · 2014: 16 · 2013: 22 · 2012: 29
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- agouti-related protein, C-terminal fragment, alpha-melanocyte-stimulating hormone, melanocortin 3 receptor, melanocortin-4 receptor, dietary intake, hyperphagia, SHU9119, obesity, hypothalamus, cAMP signaling, intracerebroventricular administration
- MeSH terms
- alpha-MSH, Animals, Dose-Response Relationship, Drug, Eating, Injections, Intraventricular, Male, Peptide Fragments, Proteins, Rats, Wistar, Receptors, Corticotropin, Intercellular Signaling Peptides and Proteins, Receptor, Melanocortin, Type 3, Rats, Agouti Signaling Protein, Agouti-Related Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review